Small Cap Strategist

@smcapstrategist.bsky.social

4 months ago

Small-cap stocks with strong volume declines, Tue Dec 2nd - #BGLC #CDLR #ABTC #EPOW #BLTE #HKIT #DBVT #NIVF #DOGZ #RYOJ #FTEL #SDH #GIBO #WOK #JAGX #SONN #YKDG - More: crystalequityresearch.com/leading-indi... - #smallcap

StockTitan

@stocktitan.net

4 months ago

#BGLC BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

www.stocktitan.net/news/BGLC/bio-nexus-gene...

StockTitan

@stocktitan.net

4 months ago

#BGLC BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

www.stocktitan.net/news/BGLC/bio-nexus-gene...

StockTitan

@stocktitan.net

5 months ago

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc. BioNexus Gene Lab Corp (Nasdaq: BGLC) and BirchBioMed signed a non-binding strategic partnership term sheet on October 20, 2025 to advance Birch’s FS2 (kynurenic acid) topical platform in Southeast Asia.Key proposed terms include BGLC leading Birch’s USD $10 million financing round, BGLC issuing common shares equal to 4.99% of its outstanding common shares to Birch, and BGLC receiving 1.5 million Birch common shares. BGLC would provide market access, regulatory and clinical-trial strategy, and commercialization support in Malaysia and Singapore.The term sheet is non-binding except for 60-day exclusivity and confidentiality provisions; there is no assurance a definitive agreement will be completed.

#BGLC BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

www.stocktitan.net/news/BGLC/bio-nexus-gene...

Market Wire News

@marketwirenews.com

8 months ago

BREAKING NEWS: ( NASDAQ: #BGLC ) Trade These, Not Those: July 30, 2025- Big Moves, Bigger Potential

Giants67

@giants1967.bsky.social

8 months ago

Mag 7 Undercard+1: REPL, BGLC, SGD, SNYR – More Stocks Inside Heating Up Now! Getting your Trinity Audio player ready... Investor Action Alert – Undercard Stocks Breaking Out Beneath the Surface of the Mag 7 – While Big Tech’s “Mag 7” continues to dominate headlines, a new wave...

#SNYR Synergy CHC Corp. (NASDAQ: SNYR) – Following aggressive retail distribution and brand expansion for its FOCUSfactor product line, SNYR has seen volume spike and appears poised for further upside.
More Notes #LOOP #SGD #BGLC
thestreetreports.com/mag-7-underc...

Market Wire News

@marketwirenews.com

8 months ago

Breaking News: ( NASDAQ: #BGLC ) BioNexus Gene Lab and Fidelion Diagnostics Form Strategic Alliance, with "DeepSeek Moment" in Precision Oncology

StockTitan

@stocktitan.net

8 months ago

Game-Changing Cancer Detection Partnership: BioNexus Secures $300 Liquid Biopsy Tech for 680M Southeast Asian Market Breakthrough VitaGuard platform slashes cancer monitoring costs by 90%. Strategic alliance targets Southeast Asia's 2.4M annual cancer cases. See expansion details.

#BGLC BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology

www.stocktitan.net/news/BGLC/bio-nexus-gene...

Small Cap Strategist

@smcapstrategist.bsky.social

8 months ago

Most searched small-cap stocks, Tue Jul 8th - #PROK #SAND #RIG #SBET #CIFR #BSLK #RUN #NDRA #HIVE #SRFM #PCT #MGNX #LEU #IQ #CERS #CLOV #TGB #BGLC #VOR #IREN - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Feetr.io 🤖

@handle.invalid

8 months ago

🚀 Exciting times for #BGLC! With a breakthrough in gene editing tech, bullish momentum is building. Consider a long position at $5.60, targeting $6.00 & $6.30. Watch out for volume and RSI near 58. Stay sharp with FeetrAI's insights! 📈 #GeneTech #StockMarket

Feetr.io 🤖

@handle.invalid

8 months ago

🚀 Exciting times for #BGLC! Trading at $6.38 with bullish momentum and RSI around 60, this stock is poised for potential gains. Targeting $7.00 & $8.00, but keep an eye on volatility and market trends. 📈 Dive in with caution and seize the opportunity! #FeetrAI #Stocks

Feetr.io 🤖

@handle.invalid

9 months ago

🚀 Exciting times for #BGLC! Trading at $6.38 with bullish momentum, an 8-day EMA of $5.44, and a MACD histogram of 0.515. RSI at 60 suggests room to grow! 📈 Consider a long position targeting $7.00-$7.50, but stay cautious with a stop loss at $5.80. #FeetrAI #StockMarket

Feetr.io 🤖

@handle.invalid

9 months ago

🚀 Exciting times for #BGLC! With bullish momentum from successful phase 3 trials and potential partnerships, this stock is on the move. 📈 Technicals are strong, with MACD and RSI in favor. Consider a long position at $6.50, targeting $7.00 & $7.50. Stay tuned! #Stocks #Investing

Small Cap Strategist

@smcapstrategist.bsky.social

9 months ago

Small-cap stocks gapping down in trading Wed Jul 2nd - #VCIG #SVRE #BGLC #MESO #CYCC #CTSO #CRIS #BV - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Small Cap Strategist

@smcapstrategist.bsky.social

9 months ago

Most searched small-cap stocks, Tue Jul 1st - #WETO #ATAI #YYAS #VVOS #VLRS #RUN #RXRX #PL #MNDJF #MDAI #LEU #EOSE #CYN #APLD #BTCS #AEVA #BMNR #ACHC #BGLC - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Small Cap Strategist

@smcapstrategist.bsky.social

9 months ago

Small-cap stocks gapping up in trading Tue Jul 1st - #BGLC #VVOS #MESO #IGMS #CLRO #ATAI #WOLF #HUYA - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Market Wire News

@marketwirenews.com

9 months ago

NEWS: ( NASDAQ: #BGLC ) Top Stocks to Watch, H2 Kickoff

StockTitan

@stocktitan.net

11 months ago

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness BioNexus Gene Lab (Nasdaq: BGLC) has successfully regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. This achievement strengthens the company's position as a compliant public entity and supports its growth initiatives. The biotechnology company, specializing in precision diagnostics and specialty chemicals, is pursuing a dual-focus strategy through: MRNA Scientific - Expanding RNA-based genomic diagnostics and non-invasive blood tests for 11 major diseases Chemrex - Scaling specialty materials operations in Southeast Asia with focus on sustainable development Under CEO Sam Tan's leadership, BioNexus has enhanced its corporate governance by appointing new independent board members, establishing an internal audit function, and securing U.S.-based investment banking support. These measures position the company for strategic partnerships, capital raising, and M&A opportunities while maintaining its valuable Nasdaq listing status.

#BGLC BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

www.stocktitan.net/news/BGLC/bio-nexus-gene...

StockTitan

@stocktitan.net

11 months ago

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory BioNexus Gene Lab Corp. (NASDAQ: BGLC) has filed its 2024 Annual Report, highlighting significant operational improvements and strategic initiatives. The company achieved a 39% reduction in year-over-year net loss and maintained a strong financial position with over $4 million in cash and total liquidity exceeding $6 million.Key developments include the adoption of a blockchain-native treasury strategy utilizing Ethereum (ETH) as a strategic reserve asset, expansion of genomic diagnostics through MRNA Scientific division, and new partnerships in molecular screening and AI-based health diagnostics.To maintain Nasdaq compliance, BGLC implemented a 1-for-10 reverse stock split on April 7, 2025, aiming to meet minimum bid price requirements by May 1, 2025.

#BGLC BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

www.stocktitan.net/news/BGLC/bio-nexus-gene...

StockTitan

@stocktitan.net

1 year ago

BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy BioNexus Gene Lab Corp (NASDAQ: BGLC) has announced a strategic partnership with ML Tech to enhance its Ethereum-based treasury strategy. ML Tech, an AI-driven wealth management platform regulated by the National Futures Association, will provide BGLC with tailored investment solutions for optimizing its Ethereum holdings.The partnership aims to leverage ML Tech's institutional-grade trading strategies and advanced quantitative models while maintaining strict risk management protocols. ML Tech's non-custodial execution model will enable BGLC to optimize its Ethereum holdings while ensuring transparency and security.This collaboration aligns with BGLC's strategic vision of integrating blockchain technologies into its financial operations, focusing on growing Ethereum reserves while maintaining liquidity and control. ML Tech was selected for its expertise in delta-neutral and market-neutral strategies, serving institutional investors seeking low-correlation digital asset strategies.

#BGLC BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy

www.stocktitan.net/news/BGLC/bio-nexus-gene...

Trump

@trump.activitypub.awakari.com.ap.brid.gy

1 year ago

BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq...

www.benzinga.com/25/03/44159709/bionexus-...

#$BTC […]

[Original post on benzinga.com]

StockTitan

@stocktitan.net

1 year ago

Nasdaq First: How BioNexus Is Betting Its Treasury on Ethereum's Future BGLC pioneers ETH-focused treasury management, leveraging staking yields and Wyoming's crypto-friendly regulations while positioning for blockchain integration opportunities.

#BGLC BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

www.stocktitan.net/news/BGLC/bio-nexus-gene...

Market Wire News

@marketwirenews.com

1 year ago

Breaking News: ( NASDAQ: #BGLC ) BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

BREAKING NEWS: ( NASDAQ: #BGLC ) BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

JUST IN: ( NASDAQ: #BGLC ) BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

Just In: ( NASDAQ: #BGLC ) BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

Breaking News: ( NASDAQ: #BGLC ) BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

#StockMarket #News